The anti-inflammatory injection, also known as adalimumab, lost its U.S. market exclusivity in early 2023 after generating hundreds of billions of dollars in sales for AbbVie (NYSE:ABBV ...

injection, 50 mg every month Certolizumab ... administration only. ADM: Adalimumab; AUC 0-∞: Area under the plasma concentration-time curve from time zero to infinity; CL/F: Apparent total ...